Stony Brook’s Gynecologic Oncology Team specializes in the diagnosis and treatment of female reproductive cancers, including cancers of the: • ovaries • uterus (endometrium) • cervix • vulva • vagina • peritoneum • fallopian tubes.
Comprehensive, multidisciplinary care is provided for women with known or suspected gynecologic cancers as well as for those with complicated gynecologic surgical needs. Conditions that are considered preinvasive such as dysplasia (a change to the lining of the cervix) are also treated by this team. Diagnostic testing, counseling and treatment are provided for those with a genetic predisposition to cancer, including breast cancer (BRCA) gene mutations and Lynch syndrome.
Led by a board-certified gynecologic oncologist, this highly experienced team treats more than 400 new patients, performs 300 surgical procedures, administers 475 chemotherapy cycles, and totals nearly 2,500 office visits a year.
Key components of the team’s work are research and education. In conjunction with the Gynecologic Oncology Group (GOG), a national research organization funded by the National Institutes of Health, team members provide patients access to cutting-edge therapy through GOG clinical studies. Resident physicians and students in obstetrics and gynecology participate in caring for patients, as well as contributing to the team’s research activities under the supervision of the attending physicians.